Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)
Clinical trial NCT03963206 · COMPLETED
Trial details
- NCT number
- NCT03963206
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-09
- Primary completion
- 2021-10-07
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.